Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering

Tissue Engineering - Part A

Volumn 15, Issue 4, 2009, Pages 923-933

  Kim, Hea Kyung ^a   Shim, Woo Sun ^a   Kim, Sung Eun ^b   Lee, Kweon Haeng ^b   Kang, Eunah ^c   Kim, Jong Ho ^c   Kim, Kwangmeyung ^c   Kwon, Ick Chan ^c   Lee, Doo Sung ^a  

^a Sungkyunkwan University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BLOCK COPOLYMERS; BONE; CELL CULTURE; COPOLYMERIZATION; ETHYLENE; ETHYLENE GLYCOL; GELATION; HYDROGELS; OLIGOMERS; POLYETHYLENE OXIDES; POLYMER SOLUTIONS; SCAFFOLDS; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE ACTIVITY; BONE TISSUE ENGINEERING; CAPROLACTONE; COPOLYMER SOLUTION; ECTOPIC BONES; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IN-SITU; IN-SITU FORMATIONS; IN-VIVO; LACTIDE; MINERALIZED TISSUE; PH SENSITIVE; PHYSIOLOGICAL CONDITION; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (RHBMP-2); RHBMP-2; SULFAMETHAZINE; THERMO SENSITIVE; THERMO-SENSITIVE HYDROGEL;

POLYETHYLENE GLYCOLS;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COPOLYMER; LACTONE DERIVATIVE; MACROGOL; OLIGOMER; POLYMER; SULFADIMIDINE; BMP2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; BIOCOMPATIBILITY; BONE TISSUE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOLOGY; HUMAN; HUMAN CELL; HYDROGEL; IN VIVO STUDY; INJECTION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; PH; PHYSIOLOGY; PRIORITY JOURNAL; TISSUE ENGINEERING; ANIMAL; BONE; BONE DEVELOPMENT; CHEMISTRY; CYTOLOGY; METABOLISM; METHODOLOGY; NUDE MOUSE; TEMPERATURE;

MUS;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; HUMANS; HYDROGEL; HYDROGEN-ION CONCENTRATION; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; OSTEOGENESIS; POLYMERS; TEMPERATURE; TISSUE ENGINEERING;

EID: 67049162753     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0407     Document Type: Article

References (36)

1. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
2. Vacanti, J.P., Langer, R., Upton, J., and Marler, J.J. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev 33, 165, 1998.
3. Petite, H., Viateau, V., Bensaid, W., Meunier, A., de Pollak, C., Bourguignon, M., Oudina, K., Sedel, L., and Guillemin, G. Tissue-engineered bone regeneration. Nat Biotechnol 18, 959, 2000.
4. Mauney, J.R., Volloch, V., and Kaplan, D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11, 787, 2005.
5. Neubauer, M., Hacker, M., Bauer-Kreisel, P., Weiser, B., Fischbach, C., Schulz, M.B., Goepferich, A., and Blunk, T. Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng 11, 1840, 2005.
6. Shin, M., Yoshimoto, H., and Vacanti, J.P. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng 10, 33, 2004.
7. Takahashi, Y., and Tabata, Y. Homogeneous seeding of mesenchymal stem cells into nonwoven fabric for tissue engineering. Tissue Eng 9, 931, 2003.
8. Zuk, P.A., Zhu, M., Ashjian, P., de Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
9. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A., and Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41, 2002.
10. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
11. Luu, H.H., Song, W.X., Luo, X., Manning, D., Luo, J., Deng, Z.L., Sharff, K.A., Montag, A.G., Haydon, R.C., and He, T.C. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25, 665, 2007.
12. Hollinger, J.O., Uludag, H., and Winn, S.R. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31, 303, 1998.
13. Gittens, S.A., and Uludag, H. Growth factor delivery for bone tissue engineering. J Drug Target 9, 407, 2001.
14. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., Israel, D.I., Hewick, R.M., Kerns, K.M., and LaPan, P. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87, 2220, 1990.
15. Meinel, L., Hofmann, S., Betz, O., Fajardo, R., Merkle, H.P., Langer, R., Evans, C.H., Vunjak-Novakovic, G., and Kaplan, D.L. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials 27, 4993, 2006.
16. Na, K., Kim, S.W., Sun, B.K., Woo, D.G., Yang, H.N., Chung, H.M., and Park, K.H. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials 28, 2631, 2007.
17. Meinel, L., Karageorgiou, V., Hofmann, S., Fajardo, R., Snyder, B., Li, C., Zichner, L., Langer, R., Vunjak-Novakovic, G., and Kaplan, D.L. Engineering bone-like tissue in vitrousing human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 71, 25, 2004.
18. Haider, M., Cappello, J., Ghandehari, H., and Leong, K.W. In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels. Pharm Res 25, 692, 2008.
19. Ikeuchi, M., Dohi, Y., Horiuchi, K., Ohgushi, H., Noshi, T., Yoshikawa, T., Yamamoto, K., and Sugimura, M. Recombinant human bone morphogenetic protein-2 promotes osteogenesis within atelopeptide type I collagen solution by combination with rat cultured marrow cells. J Biomed Mater Res 60, 61, 2002.
20. Hedberg, E.L., Shih, C.K., Lemoine, J.J., Timmer, M.D., Liebschner, M.A., Jansen, J.A., and Mikos, A.G. In vitro degradation of porous poly(propylene fumarate)=poly(DL-lactic-coglycolic acid) composite scaffolds. Biomaterials 26, 3215, 2005.
21. Behravesh, E., Jo, S., Zygourakis, K., and Mikos, A.G. Synthesis of in situ cross-linkable macroporous biodegradable poly(propylene fumarate-co-ethylene glycol) hydrogels. Biomacromolecules 3, 374, 2002.
22. Trojani, C., Boukhechba, F., Scimeca, J.C., Vandenbos, F., Michiels, J.F., Daculsi, G., Boileau, P., Weiss, P., Carle, G.F., and Rochet, N. Ectopic bone formation using an injectable biphasic calcium phosphate=Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials 27, 3256, 2006.
23. Choi, Y.S., Park, S.N., and Suh, H. Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 26, 5855, 2005.
24. Jeon, O., Song, S.J., Kang, S.W., Putnam, A.J., and Kim, B.S. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(Llactic- co-glycolic acid) scaffold. Biomaterials 28, 2763, 2007.
25. Fu, K., Pack, D.W., Klibanov, A.M., and Langer, R. Visual evidence of acidic environment within degrading poly(lacticco- glycolic acid) (PLGA) microspheres. Pharm Res 17, 100, 2000.
26. Qingpu Hou, P.A.D.B.K.M.S. Injectable scaffolds for tissue regeneration. J Mater Chem 14, 1915, 2004.
27. Kretlow, J.D., Klouda, L., and Mikos, A.G. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 59, 263, 2007.
28. Yamada, Y., Ueda, M., Naiki, T., Takahashi, M., Hata, K., and Nagasaka, T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissueengineered bone regeneration. Tissue Eng 10, 955, 2004.
29. Shim, W.S., Kim, J.H., Park, H., Kim, K., Chan Kwon, I., and Lee, D.S. Biodegradability and biocompatibility of a pHand thermo-sensitive hydrogel formed from a sulfonamidemodified poly(epsilon-caprolactone-co-lactide)- poly(ethylene glycol)-poly(epsilon-caprolactone-co-lactide)blockcopolymer. Biomaterials 27, 5178, 2006.
30. Shim, W.S., Kim, S.W., and Lee, D.S. Sulfonamide-based pHand temperature-sensitive biodegradable block copolymer hydrogels. Biomacromolecules 7, 1935, 2006.
31. Shim, W.S., Yoo, J.S., Bae, Y.H., and Lee, D.S. Novel injectable pH and temperature sensitive block copolymer hydrogel. Biomacromolecules 6, 2930, 2005.
32. Yan, H., Saiani, A., Gough, J.E., and Miller, A.F. Thermoreversible protein hydrogel as cell scaffold. Biomacromolecules 7, 2776, 2006.
33. ISO document 10993. Biological compatibility of medical devices. 5. Test for cytotoxicity: in vitro methods. 1992. www.iso.org/iso.
34. Vert, M., Li, S., and Garreau, H. More about the degradation of LA=GA-derived matrices in aqueous media. J Controlled Release 16, 15, 1991.
35. Yoshida, K., Bessho, K., Fujimura, K., Kusumoto, K., Ogawa, Y., Tani, Y., and Iizuka, T. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J Craniomaxillofac Surg 26, 112, 1998.
36. Kroese-Deutman, H.C., Ruhe, P.Q., Spauwen, P.H., and Jansen, J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 26, 1131, 2005.